{
  "@context": {
    "biotools": "https://bio.tools/ontology/",
    "bsc": "http://bioschemas.org/",
    "bsct": "http://bioschemas.org/types/",
    "dct": "http://purl.org/dc/terms/",
    "edam": "http://edamontology.org/",
    "rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
    "rdfs": "http://www.w3.org/2000/01/rdf-schema#",
    "sc": "http://schema.org/",
    "xsd": "http://www.w3.org/2001/XMLSchema#"
  },
  "@graph": [
    {
      "@id": "https://doi.org/10.1016/J.DMPK.2020.05.007",
      "@type": "sc:CreativeWork"
    },
    {
      "@id": "https://bio.tools/premetabo",
      "@type": "sc:SoftwareApplication",
      "dct:conformsTo": "https://bioschemas.org/profiles/ComputationalTool/0.6-DRAFT",
      "sc:applicationSubCategory": [
        {
          "@id": "edam:topic_2275"
        },
        {
          "@id": "edam:topic_0821"
        },
        {
          "@id": "edam:topic_3407"
        },
        {
          "@id": "edam:topic_0154"
        },
        {
          "@id": "edam:topic_3375"
        }
      ],
      "sc:citation": [
        {
          "@id": "https://doi.org/10.1016/J.DMPK.2020.05.007"
        },
        "pubmed:32616370"
      ],
      "sc:description": "An in silico phase I and II drug metabolism prediction platform.\n\nPreMetabo â€“ Just another BMDRC Sites site.\n\nCYP 2C9, 2C19, 2D6, 3A4 Inhibitor / Non-inhibitor, CYP 2D6, 3A4 Substrate / Non-substrate.\n\nCYP 3A4, 1A2, 2C9, 2D6 Site of Metabolism (SOM) prediction.",
      "sc:featureList": [
        {
          "@id": "edam:operation_3896"
        },
        {
          "@id": "edam:operation_3454"
        },
        {
          "@id": "edam:operation_3929"
        },
        {
          "@id": "edam:operation_0478"
        }
      ],
      "sc:name": "PreMetabo",
      "sc:url": "https://premetabo.bmdrc.kr/"
    }
  ]
}